These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25558074)

  • 1. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis.
    Jones GR; Cumming DV; Honeywell G; Ball R; Sanderson F; Seaton RA; Healy B; Hedderwick S; Gilchrist M;
    J Antimicrob Chemother; 2015 Apr; 70(4):1236-40. PubMed ID: 25558074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis.
    Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K
    CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
    Sumpter C; Russell CD; Mackintosh C
    Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
    Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study.
    Yadav K; Mattice AMS; Yip R; Rosenberg H; Taljaard M; Nemnom MJ; Ohle R; Yan J; Suh KN; Stiell IG; Eagles D
    Intern Emerg Med; 2021 Oct; 16(7):1935-1944. PubMed ID: 33515424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
    Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
    Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient parenteral antibiotic therapy: principles and practice.
    Seaton RA; Barr DA
    Eur J Intern Med; 2013 Oct; 24(7):617-23. PubMed ID: 23602223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis.
    Quirke M; Curran EM; O'Kelly P; Moran R; Daly E; Aylward S; McElvaney G; Wakai A
    Postgrad Med J; 2018 Jan; 94(1107):25-31. PubMed ID: 28874503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    Bazaz R; Chapman AL; Winstanley TG
    J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
    Seaton RA; Bell E; Gourlay Y; Semple L
    J Antimicrob Chemother; 2005 May; 55(5):764-7. PubMed ID: 15772137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.
    Zhang J; Moore E; Bousfield R
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1013-5. PubMed ID: 27084095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making a case for outpatient parenteral antimicrobial therapy (OPAT).
    Seaton RA; Gilchrist M
    J Antimicrob Chemother; 2024 Aug; 79(8):1723-1724. PubMed ID: 38874182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT).
    Palit J; Cole J; Durojaiye OC
    Diagn Microbiol Infect Dis; 2021 May; 100(1):115305. PubMed ID: 33454560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.